Drug Testing Locations - Rutherford, NJ

Drug Testing in Rutherford, NJ

Rutherford, New Jersey Statistics

In 2022, Bergen County, which includes Rutherford, NJ, reported 200 opioid-related deaths.

Rutherford, NJ saw a 15% increase in drug treatment admissions in 2022, according to Bergen County reports.

Bergen County, home to Rutherford, NJ, recorded a 20% increase in heroin-related arrests in 2022.

The 2023 Community Needs Assessment in Rutherford, NJ highlighted substance abuse as a key concern.

In 2021, Bergen County, including Rutherford, NJ, had 1,500 drug-related emergency room visits.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Rutherford, NJ & Drug Testing Policies

Employers in Rutherford, NJ, keen on maintaining a drug-free workplace, typically enforce strict drug testing policies. These include pre-employment screenings and random drug testing throughout employment to ensure compliance and safety in the workplace.

Many Rutherford employers are aligning with state guidelines provided by the New Jersey Department of Labor and Workforce Development (link). These guidelines emphasize preventative measures and educate employers on maintaining a healthy workforce.

Furthermore, companies in this region often include rehabilitation support in their employee benefits packages, encouraging a supportive approach toward employees seeking help with substance abuse.

Government Efforts with Drug Problems in Rutherford, NJ

The local government in Rutherford, NJ has implemented various initiatives to combat drug abuse, such as increased funding for drug education programs in schools. The Bergen County Prosecutor's Office (link) provides resources and support for tackling drug-related issues.

The state government has also launched the New Jersey Addiction Services Hotline (link), offering assistance to Rutherford residents. Additionally, federal efforts like grants to local law enforcement have been made to reduce drug trafficking in Bergen County.

Local Drug Busts & News in Rutherford, NJ

Rutherford, NJ, like many communities, has been working to combat drug-related issues. Local law enforcement has placed a strong emphasis on stopping drug trafficking and sales within the community. The efforts have led to several successful operations, resulting in significant drug busts in recent months. These operations often involve collaboration between local police, state agencies, and even federal authorities.

One recent drug bust in Rutherford involved a coordinated effort between police departments across Bergen County. The operation targeted a network suspected of distributing opioids in the area. After weeks of surveillance, multiple arrests were made, and a large quantity of narcotics was seized, significantly impacting the availability of these drugs on the streets and ensuring enhanced safety for residents.

Community outreach programs have also been implemented alongside enforcement actions to address the broader issue of drug abuse in Rutherford. These initiatives aim to educate the public, especially young people, about the dangers of drug use and the importance of making informed decisions. Workshops and seminars held at schools and community centers have been instrumental in preventing substance abuse.

Rutherford police continue to strengthen community ties, promoting a safer environment by encouraging residents to report suspicious activities. These collaborations are essential for the timely identification and disruption of drug-related operations. By keeping lines of communication open, Rutherford is not only tackling current drug issues but also laying the foundation for long-term prevention and community resilience.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Rutherford, NJ. Trusted by employers nationwide for accurate results and exceptional service.

New Jersey DOT/Non DOT Physicals

New Jersey Vision Tests

New Jersey Audiograms

New Jersey Respirator Fit Tests

New Jersey Lift Tests

New Jersey Background Checks

Clinical Testing Services

TB Testing in NJ

Diabetes Testing in NJ

Infectious Disease Testing in NJ

Sickle Cell Anemia Testing in NJ

Women/Men's Health Testing in NJ

Resources & Citations

NJ 211 Addiction Services

Partnership for a Drug-Free New Jersey

Valley Health System

Bergen County Health Promotion

DEA's National Take-Back Event

NJ's Drug Abuse Initiative

Prevention Links NJ

Substance Use Disorder Report NJ

Bergen ResourceNet

NJ Integrated Health

Drug Testing Near Rutherford, NJ

Belleville, NJ

North Arlington, NJ

Moonachie, NJ

Nutley, NJ

Hasbrouck Heights, NJ

Wallington, NJ

Wood-Ridge, NJ

Lyndhurst, NJ

Carlstadt, NJ

East Rutherford, NJ

Frequently Asked Questions

Customer Reviews